Belani Kiran, Leibowitz Akiva, Bose Somnath
From the Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
A A Pract. 2018 Aug 15;11(4):93-95. doi: 10.1213/XAA.0000000000000751.
An 81-year-old woman with extensive peripheral vascular and coronary artery disease was admitted to the intensive care unit with a deep heel abscess and urinary tract infection. When cultures from the heel ulcer yielded vancomycin-resistant enterococci, she was started on the antibiotic linezolid. After several days of intravenous linezolid therapy, she developed severe lactic acidosis (pH 6.89) and elevation of pancreatic enzymes. An emergent exploratory laparotomy was performed to rule out mesenteric ischemia. Findings from the laparotomy were negative, and after elimination of other differential diagnoses, the metabolic acidosis was ultimately attributed to linezolid. Acidosis resolved after discontinuation of linezolid.
一名患有广泛外周血管疾病和冠状动脉疾病的81岁女性因足跟深部脓肿和尿路感染入住重症监护病房。足跟溃疡培养物检测出耐万古霉素肠球菌后,开始给予她抗生素利奈唑胺治疗。静脉注射利奈唑胺治疗几天后,她出现了严重的乳酸酸中毒(pH 6.89)以及胰腺酶升高。为排除肠系膜缺血进行了急诊剖腹探查术。剖腹探查结果为阴性,在排除其他鉴别诊断后,代谢性酸中毒最终归因于利奈唑胺。停用利奈唑胺后酸中毒得到缓解。